![]() |
|
| DVC Senior Management Team - Back row (left to right): Linda Dunsmoor, Steve Griffith, Bonny Bass, Mike McGinnis; Front row: April Finnen, Dr. Robert House, Dr. Mary Kate Hart, Joel Malagari |
|
Robert V. House, M.S.P.H., Ph.D. is President of DynPort Vaccine Company LLC (DVC), a CSC Company. DVC is a biotechnology firm that manages product development programs for U.S. Government agencies and provides consulting, technical and program management services to companies in the biotechnology and pharmaceutical industries. Prior to joining DVC, Dr. House worked at Covance Laboratories in Madison, Wis., and IIT Research Institute in Chicago, Ill., where he managed highly successful programs in immunotoxicology assessment. He has more than 20 years of experience in biomedical research and development, specializing in the assessment of inadvertent and therapeutic immunomodulation. Dr. House earned his Master of Science in Public Health in Parasitology and Laboratory Practice and his Ph.D. in Medical Parasitology from the University of North Carolina at Chapel Hill School of Public Health. He is the author or co-author of more than 100 journal articles, book chapters and books covering immunology, immunotoxicology, infectious disease and biodefense. He has also participated in numerous working groups and expert panels in the field of immunotoxicology and is a frequent speaker at conferences and educational seminars.
Mary Kate Hart, Ph.D. serves as Chief Scientific Officer at DVC where she is responsible for setting and managing the overall scientific and technical direction for development of all existing and anticipated products under development at DVC. Dr. Hart joined DVC in 2006 as Director of Nonclinical Research, developing, managing and leading the company’s Nonclinical department toward successful licensure of vaccines under the U.S. Food and Drug Administration (FDA) Animal Rule. Dr. Hart also served as Principal Investigator for DVC’s seasonal and pandemic influenza vaccine program. Prior to joining DVC, Dr. Hart worked at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) at Fort Detrick in Frederick, Md. for 15 years. She has more than 20 years of experience in vaccine research and development and has published over 30 peer-reviewed manuscripts, chapters and reviews, holds 7 patents and has received several awards. Dr. Hart earned a B.S. in Biology from St. Joseph’s University in Philadelphia, and her Ph.D. in Immunology from the University of Pennsylvania. Dr. Hart is an honorary adjunct faculty member for the Biomedical Sciences Program at Hood College, and has taught undergraduate immunology courses.
Linda Dunsmoor is the Head of Quality at DVC. She is responsible for overseeing staff responsible for Good Laboratory Practice (GLP), Current Good Manufacturing Practice (CGMP) and Good Clinical Practice (GCP) compliance activities. Ms. Dunsmoor joined DVC in 2002 as Product Quality Assurance Manager and in 2005 began managing the Clinical Quality Assurance department. Prior to joining DVC, Ms. Dunsmoor worked at Life Technologies/Invitrogen in Frederick, Md. for 13 years. She has 23 years experience in the biotechnology field, 19 years in quality systems and 15 years of experience in management. Ms. Dunsmoor earned a B.S. from California University of Pennsylvania and holds multiple certifications in areas of quality systems management.
Joel Malagari has served as Director of Finance at DVC since 2001, where he is responsible for managing product financial analysts. These analysts provide the budgeting, estimating and Earned Value Management System (EVMS) support to the integrated product teams charged with the development of FDA-licensed products for DVC clients. He also works closely with the DVC President in planning and forecasting DVC’s finances. Prior to joining DVC, Mr. Malagari worked at Orbital Sciences Corporation in Germantown, Md. for 13 years. He has over 29 years of program financial planning, budgeting, execution and EVMS experience in private industry, supporting a variety of Department of Defense and civil government contracts. Twenty-five of those years have been in a management role, providing leadership, training and mentoring. Mr. Malagari earned a B.S. in Management/Finance from SUNY at Utica, College of Technology.
Bonny Bass is the Director of Program Management at DVC. Ms. Bass is responsible for the oversight and leadership of all DVC projects, program managers and project managers. Ms. Bass joined DVC in 2001 as Senior Project Manager for DVC's plague vaccine development program. In 2006, she began managing the advanced development of seasonal and pandemic influenza vaccines for the Biomedical Advanced Research and Development Authority (BARDA). Prior to joining DVC, Ms. Bass worked for Quality Biological, Inc. in Gaithersburg, Md. for eight years. She has more than 17 years of experience in project management and 5 years of experience in research and development and currently holds a Project Management Professional (PMP) certification. Ms. Bass earned a B.S. in Biology from the University of South Florida and an M.S. in Microbiology from the University of Central Florida.
Michael S. McGinnis is Director of New Business for DVC, where he is responsible for leading DVC’s new business activities and functions. Prior to joining DVC, Mr. McGinnis worked at ICON Clinical Research in North Wales, PA and MedTrials, Inc. in Dallas, TX, where he held various leadership roles with global business development and marketing responsibilities. He has more than 12 years of relevant business development and marketing experience within the Pharmaceutical/Biotechnology arena. Mr. McGinnis earned a B.S. in Business Administration from Towson University in Maryland and an M.B.A. from Loyola University in Maryland.
Steven Griffith is Senior Manager, Contracts for DVC. Mr. Griffith and the Contracts/Subcontracts staff provide CSC contractual support and oversight for DVC. Mr. Griffith joined CSC/DVC in 2010. He has more than 20 years experience in Federal Government acquisition and contracting as a contracting officer and contracts manager in support of defense and intelligence agencies. Mr. Griffith earned a B.S. in Business Administration from The Citadel, and an M.B.A. from the University of South Dakota. He also graduated from the Defense Acquisition University's Advanced Program Management Course, and holds the Certified Professional Contracts Manager (CPCM) designation from the National Contract Management Association.
April L. Finnen is Associate Director of Communications at DVC. Ms. Finnen joined DVC in 2003, and currently serves as Communications department head, where she oversees internal, external and marketing communications. Ms. Finnen earned a B.A. in Journalism and Mass Communication from the University of North Carolina at Chapel Hill, and an M.B.A. from the University of Florida. She has experience in pharmaceutical, technology and non-profit communications, and has taught public relations writing at Hood College in Maryland.
Related Links
Contact us to request a DVC expert as a speaker for industry events.
Learn more about Dr. House's thoughts on the industry in his Bugs and Drugs Blog.
